Medical - Healthcare Plans · NYSE
Current Price
$194.82
PE Ratio (TTM)
1217.6x
Intrinsic Value
Use the calculator below to estimate
COMPETITIVE MOAT
↑Government Contract Expertise
Molina excels in navigating complex government contracts for Medicaid and Medicare. This deep regulatory understanding creates high barriers to entry for new competitors.
↑Niche Market Focus
Specializing in serving low-income and vulnerable populations provides a dedicated customer base. This focus allows for tailored services and strong community relationships.
↑Scale in Government Programs
Significant scale within government-sponsored health plans allows for operational efficiencies and cost advantages. This scale is difficult for smaller players to replicate.
INVESTMENT RISKS
↓Dependence on Government Reimbursement
Molina's revenue is heavily reliant on government funding. Any reduction or changes in these programs poses a significant financial risk.
↓Execution Risk in Acquisitions
While acquisitions support growth, integrating new entities can be complex. Poor execution could lead to financial strain or operational disruptions.
↓Competition from Larger Insurers
Larger, more diversified health insurers can leverage greater resources. This competition can make it challenging to win and retain government contracts.
Adjust the target PE, earnings growth, and discount rate to see how the fair value and margin of safety for Molina Healthcare, Inc. respond.
Open PE Calculator for MOHMolina Healthcare, Inc. offers comprehensive managed health care services, primarily targeting economically disadvantaged families and individuals. The company provides coverage through key government initiatives such as Medicaid and Medicare programs, in addition to state health insurance marketplaces. Its operations are strategically segmented into four main divisions: Medicaid, Medicare, Marketplace, and a general "Other" category. By the close of 2021, specifically December 31st, Molina Healthcare's network extended to approximately 5.2 million members across 18 states, all of whom qualified for Medicaid, Medicare, or other government-sponsored healthcare plans. Established in 1980, the company maintains its corporate headquarters in Long Beach, California.
PE Ratio (TTM)
1217.6x
PEG Ratio
n/m
Earnings Yield
-0.07%
ROE (TTM)
-0.2%
Revenue/Share (TTM)
$867.88
Debt/Equity
0.95x
The trailing twelve-month PE ratio of MOH reflects how much investors pay per dollar of Molina Healthcare, Inc.'s earnings. This metric is most useful when compared to Medical - Healthcare Plans peers and the company's own historical range.
MOH's PE of 1217.6x combined with a PEG ratio of -12.27 provides a growth-adjusted perspective. MOH has negative earnings, so its PE and PEG ratios are not meaningful here and cannot tell you whether the stock is over or undervalued. Keep in mind that PE-based valuation works best for profitable, mature companies — for high-growth or cyclical Medical - Healthcare Plans, a DCF analysis may be more appropriate.
To value Molina Healthcare, Inc. using PE: (1) Compare the current PE (1217.6x) against the Medical - Healthcare Plans median to assess relative pricing, (2) check the PEG ratio (-12.27) to adjust for growth expectations, (3) review the 5-year PE range to identify where the stock sits historically, and (4) estimate fair value by multiplying a target PE by forward EPS estimates. This relative approach complements DCF's absolute valuation.
MOH's PEG ratio is -12.27, calculated by dividing the PE ratio (1217.6x) by the expected earnings growth rate. Because MOH has negative earnings, its PEG ratio is not meaningful and should not be read as a sign of under or overvaluation. Note that PEG accuracy depends on the reliability of growth estimates.
PE ratio gives a quick relative read — how MOH is priced versus Medical - Healthcare Plans peers. DCF provides an absolute value based on projected free cash flows. For the most reliable valuation, use PE as a quick comparability screen and DCF for a deeper fundamental analysis. Each method has blind spots: PE ignores capital structure and cash flow quality, while DCF is sensitive to growth and discount rate assumptions.
P/E and DCF value MOH with different methods and assumptions, so the two conclusions can differ. Compare the DCF intrinsic value.
Price as of 2026-10-07. Financial data from Financial Modeling Prep (trailing twelve months) · Valuation methodology by Charlie Wang.
This is an estimate, not investment advice.